V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200015189 | 200006449 | null | null | Palliative (P) | 2013-09-08 | 2013-09-08 | Bortezomib + Panobinostat | N | null | 200043763 | ABC-02 TRIAL |
| 300004536 | 300003172 | 0 | 104 | Curative (C) | 2018-03-12 | 2018-03-12 | TEMOZOLOMIDE | N | N | 300024268 | ABC-02 TRIAL |
| 200015906 | 200006711 | 0.64 | null | null | 2015-10-08 | 2015-10-09 | VDT-PACE | N | N | 200022979 | ABC-02 TRIAL |
| 280005540 | 280003522 | 1.63 | 93.4 | Palliative (P) | 2017-03-01 | 2017-03-11 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 280029283 | ABC-03 TRIAL |
| 10003304 | 10002112 | 1.85 | 71 | Adjuvant (A) | 2015-03-11 | 2015-03-15 | IMATINIB | N | N | 10469047 | ABIRATERONE |
| 280010780 | 280006660 | 1.77 | 119 | Palliative (P) | 2016-05-18 | 2016-06-15 | NIVOLUMAB | Y | N | 280020449 | ABIRATERONE |
| 10003495 | 10002220 | 1.71 | null | Adjuvant (A) | 2009-11-21 | 2017-10-11 | CTD | 2 | N | 10480234 | ABIRATERONE |
| 10003560 | 10002260 | 1.77 | 90.4 | Palliative (P) | 2017-07-22 | 2017-07-23 | Capecitabine + Cisplatin | 02 | N | 10482169 | ABIRATERONE |
| 10003575 | 10002270 | 1.7 | 78.4 | Disease modification (D) | 2016-06-15 | 2016-06-23 | Cisplatin + Etoposide (3 day) | 2 | N | 10482879 | ABIRATERONE |
| 10003624 | 10002297 | null | null | Palliative (P) | 2015-12-30 | 2015-12-30 | BCG Intravesical | 02 | N | 10484477 | ABIRATERONE |
| 10003444 | 10002190 | 1.76 | 85 | Disease modification (D) | null | 2015-10-15 | EC | N | N | 10478482 | ABIRATERONE |
| 10003473 | 10002204 | 1.71 | null | Neo-adjuvant (N) | 2017-11-30 | 2017-11-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10479742 | ABIRATERONE |
| 10003469 | 10002201 | null | 87.599 | Curative (C) | 2014-04-19 | 2014-04-20 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | 10479416 | ABIRATERONE |
| 10003425 | 10002179 | 1.57 | 68.4 | Palliative (P) | 2017-01-28 | 2017-02-17 | CAPECITABINE + GEMCITABINE | 02 | N | 10476675 | ABIRATERONE |
| 220014710 | 220009316 | null | 70.5 | Curative (C) | 2016-05-04 | 2017-01-15 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 220035190 | ABIRATERONE |
| 230000480 | 230000280 | null | null | Adjuvant (A) | 2014-06-28 | 2014-07-05 | Capecitabine 35days + RT | N | null | 230004260 | ABIRATERONE |
| 10003487 | 10002214 | 1.6 | 77.4 | Neo-adjuvant (N) | 2017-01-27 | 2017-03-09 | BCG Intravesical | 02 | N | 10480101 | ABIRATERONE |
| 230001362 | 230000968 | null | null | Palliative (P) | 2017-01-16 | 2017-01-17 | FLUOROURACIL + OXALIPLATIN | 02 | N | 230015009 | ABIRATERONE |
| 230001657 | 230001342 | 1.73 | 59.6 | Palliative (P) | 2018-04-07 | 2018-04-15 | IVA | N | null | 230001759 | ABIRATERONE |
| 230001725 | 230001002 | 1.69 | 74.8 | Curative (C) | 2018-02-04 | 2018-09-24 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 230023578 | ABIRATERONE |
| 240008147 | 240005001 | 1.74 | null | Curative (C) | 2016-04-14 | 2016-04-25 | FCR Oral - Cycle 1 | N | N | 240002216 | ABIRATERONE |
| 240008183 | 240005020 | 1.75 | 103 | Palliative (P) | 2014-07-28 | 2014-08-07 | Methotrexate intrathecal | N | N | 240003031 | ABIRATERONE |
| 240008664 | 240005288 | 1.76 | null | null | 2015-07-15 | 2015-07-31 | Cyclophosphamide Weekly PO | null | N | 240019785 | ABIRATERONE |
| 230001228 | 230000827 | 1.73 | 97.499 | Adjuvant (A) | 2018-02-17 | 2018-03-03 | R GCVP | 2 | N | 230004137 | ABIRATERONE |
| 250010674 | 250012128 | null | null | Palliative (P) | null | 2014-08-01 | Cytarabine Low Dose | null | N | 250031610 | ABIRATERONE |
| 260008249 | 260005566 | 1.8 | null | Palliative (P) | 2014-05-29 | 2014-05-29 | Rituximab | 01 | N | 260027509 | ABIRATERONE |
| 260014387 | 260014621 | 1.73 | 97.7 | Palliative (P) | 2017-07-08 | 2017-07-08 | ESHAP | N | N | 260029416 | ABIRATERONE |
| 270009606 | 270012809 | 1.73 | 119 | Neo-adjuvant (N) | 2014-07-10 | 2014-07-26 | Carboplatin AUC 6 - 10 | 02 | N | 270019709 | ABIRATERONE |
| 270009721 | 270005745 | 1.6 | 60.2 | Neo-adjuvant (N) | 2015-11-11 | 2015-11-13 | CETUXIMAB + RT | 2 | Y | 270020403 | ABIRATERONE |
| 270010683 | 270006287 | 1.6 | 69.7 | Curative (C) | 2015-01-31 | 2015-02-27 | ECX | N | Y | 270010424 | ABIRATERONE |
| 270010867 | 270006404 | 1.8 | 79.9 | Palliative (P) | 2017-11-25 | 2017-12-07 | Capecitabine + Cisplatin | N | N | 270023944 | ABIRATERONE |
| 270015076 | 270015085 | null | null | Curative (C) | 2017-08-08 | 2017-08-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270025265 | ABIRATERONE |
| 270017295 | 270010857 | 1.68 | null | Palliative (P) | 2016-10-19 | 2018-01-24 | GEMCARBO | N | null | 270020199 | ABIRATERONE |
| 270019717 | 270018562 | 1.67 | 48.7 | Palliative (P) | 2017-08-21 | 2017-09-01 | Carbo F | N | N | 270025137 | ABIRATERONE |
| 280005489 | 280003495 | 1.64 | 70.2 | Palliative (P) | 2014-01-11 | 2014-02-26 | Cisplatin + Doxorubicin | N | N | 280029169 | ABIRATERONE |
| 230001110 | 230000682 | 1.61 | 61.7 | Palliative (P) | 2013-09-06 | 2013-09-20 | AFLIBERCEPT + FU + IRINOTECAN | N | null | 230023028 | ABIRATERONE |
| 280005752 | 280011092 | 1.08 | null | Palliative (P) | 2017-08-08 | 2017-08-08 | CAPECITABINE + GEMCITABINE | 02 | N | 280029639 | ABIRATERONE |
| 280006601 | 280004041 | 1.68 | 60 | Palliative (P) | 2013-08-11 | 2013-08-11 | Enzalutamide | N | N | 280022848 | ABIRATERONE |
| 280006714 | 280004101 | null | null | Palliative (P) | 2015-08-26 | 2015-08-30 | Capecitabine + Oxaliplatin 21day | N | null | 280029192 | ABIRATERONE |
| 250007295 | 250009707 | null | null | Palliative (P) | 2015-09-06 | 2016-05-22 | AML18 PILOT TRIAL | 02 | N | 250031720 | ABIRATERONE |
| 290004957 | 290003626 | null | 68.4 | Curative (C) | 2017-03-08 | 2017-03-21 | OCTREOTIDE | N | Y | 290022099 | ABIRATERONE |
| 290008221 | 290005125 | 1.74 | null | Palliative (P) | 2017-03-19 | 2017-03-19 | CARBOPLATIN + ETOPOSIDE | N | N | 290020664 | ABIRATERONE |
| 320002873 | 320001706 | 1.76 | 102.4 | Palliative (P) | 2013-08-23 | 2013-09-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320017017 | ABIRATERONE |
| 310005290 | 310002433 | 1.73 | null | Palliative (P) | 2014-12-26 | 2014-12-28 | Doxorubicin + Ifosfamide | 02 | N | 310007286 | ABIRATERONE |
| 310008328 | 310005502 | 1.85 | 77 | Palliative (P) | 2013-10-16 | 2013-10-20 | Erlotinib | N | N | 310007470 | ABIRATERONE |
| 310009809 | 310005230 | 1.64 | 61 | Palliative (P) | 2016-10-12 | 2016-10-14 | Cytarabine HD + Methotrexate HD | N | N | 310024278 | ABIRATERONE |
| 310010686 | 310009875 | null | 46.6 | Curative (C) | 2014-01-09 | 2014-01-09 | Dacarbazine | 02 | N | 310019978 | ABIRATERONE |
| 310010725 | 310005188 | 1.82 | 66.1 | Palliative (P) | 2016-12-06 | 2016-12-24 | DABRAFENIB + TRAMETINIB | Y | N | 310023544 | ABIRATERONE |
| 310010846 | 310005594 | 1.82 | 68 | Adjuvant (A) | 2014-11-06 | 2015-03-24 | Lenalidomide Cycle 26 onwards (PAS) | 02 | N | 310022639 | ABIRATERONE |
| 230001301 | 230000910 | 1.58 | 63.6 | Palliative (P) | 2017-03-12 | 2017-04-03 | Capecitabine + Oxaliplatin 21day | 2 | N | 230008715 | ABIRATERONE |